Analysen von James Gordon
| 27.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.06.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.06.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.06.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 20.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.05.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 25.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 23.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 15.03.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 19.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.02.24 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.01.24 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 30.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 15.01.24 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.01.24 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.12.23 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 12.12.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.12.23 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 01.12.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 21.11.23 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 17.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.11.23 | MorphoSys Overweight | JP Morgan Chase & Co. | |
| 03.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.11.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.10.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.10.23 | GSK Underweight | JP Morgan Chase & Co. | |